Theranos CEO faces critics, presents new product plans

The chief executive of embattled Theranos Inc on Monday presented plans for a new product and said the blood testing company was working diligently to rectify all of its outstanding issues involving its product and laboratory operations. CEO Elizabeth Holmes described new technologies that she said were "distinct from the operations of our clinical laboratories" that have come under scrutiny - part of a presentation before some 2,650 scientists at the American Association for Clinical Chemistry meeting in Philadelphia. It was her first public appearance since the privately held company and Holmes personally were sanctioned by the U.S. government's Centers for Medicare & Medicaid Services.